A detailed history of Asb Consultores, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Asb Consultores, LLC holds 12,540 shares of PFE stock, worth $324,660. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,540
Previous 15,558 19.4%
Holding current value
$324,660
Previous $435,000 16.78%
% of portfolio
0.15%
Previous 0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$27.7 - $31.39 $83,598 - $94,735
-3,018 Reduced 19.4%
12,540 $362,000
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $84,898 - $99,485
-3,361 Reduced 17.77%
15,558 $435,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $301,851 - $346,622
11,659 Added 160.59%
18,919 $525,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $185,209 - $240,566
-7,088 Reduced 49.4%
7,260 $209,000
Q3 2023

Nov 28, 2023

SELL
$32.09 - $37.51 $133,526 - $156,079
-4,161 Reduced 22.48%
14,348 $475,000
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $45,980 - $53,198
1,273 Added 7.39%
18,509 $678,000
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $219,284 - $285,475
5,567 Added 47.71%
17,236 $703,000
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $38,368 - $50,085
-919 Reduced 7.3%
11,669 $598,000
Q3 2022

Jan 11, 2023

BUY
$43.76 - $53.42 $66,121 - $80,717
1,511 Added 13.64%
12,588 $551,000
Q2 2022

Jan 11, 2023

BUY
$46.53 - $55.17 $28,848 - $34,205
620 Added 5.93%
11,077 $581,000
Q1 2022

Jan 11, 2023

BUY
$45.75 - $56.69 $478,407 - $592,807
10,457 New
10,457 $541,000
Q4 2021

Jan 11, 2023

SELL
$41.32 - $61.25 $92,928 - $137,751
-2,249 Reduced 17.87%
10,339 $611,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Asb Consultores, LLC Portfolio

Follow Asb Consultores, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.